December 21, 2023 05:30 AM ESTUpdated 06:57 AM
Peer Review

Deck the halls with res­ig­na­tions: Lian­Bio CEO, CFO out; CRISPR Ther­a­peu­tics CMO to leave in Jan­u­ary

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ On Dec. 16, Yizhe Wang turned in his res­ig­na­tion as CEO of Lian­Bio, while board mem­ber and Per­cep­tive chief in­vest­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times